Coherent Stock Price, News & Analysis (NASDAQ:COHR)

Coherent trades on the NASDAQ under the ticker symbol "COHR."

Coherent declared that its Board of Directors has authorized a share repurchase program on Thursday, February 8th 2018, which allows the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

Coherent, Inc. (NASDAQ:COHR) released its earnings results on Tuesday, July, 30th. The scientific and technical instruments company reported $1.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.28. The scientific and technical instruments company had revenue of $339.17 million for the quarter, compared to the consensus estimate of $348.61 million. Coherent had a net margin of 8.12% and a return on equity of 13.38%. Coherent's quarterly revenue was down 29.7% on a year-over-year basis. During the same period last year, the company earned $3.51 EPS. View Coherent's Earnings History.

Coherent is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Coherent.

9 analysts have issued 1 year target prices for Coherent's stock. Their forecasts range from $125.00 to $175.00. On average, they anticipate Coherent's share price to reach $150.00 in the next twelve months. This suggests that the stock has a possible downside of 5.5%. View Analyst Price Targets for Coherent.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Coherent in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Coherent.

News coverage about COHR stock has trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Coherent earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news articles about the scientific and technical instruments company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Coherent.

Coherent saw a decrease in short interest in the month of September. As of September 15th, there was short interest totalling 1,680,000 shares, a decrease of 6.1% from the August 15th total of 1,790,000 shares. Based on an average trading volume of 340,500 shares, the days-to-cover ratio is currently 4.9 days. Currently, 7.1% of the shares of the stock are sold short. View Coherent's Current Options Chain.

Some companies that are related to Coherent include Waters (WAT), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), PerkinElmer (PKI), Avantor (AVTR), Bruker (BRKR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), HTG Molecular Diagnostics (HTGM) and Arrayit (ARYC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Coherent investors own include NVIDIA (NVDA), Alibaba Group (BABA), Lam Research (LRCX), Adobe (ADBE), Micron Technology (MU), Broadcom (AVGO), Netflix (NFLX), Paypal (PYPL), NetEase (NTES) and Applied Materials (AMAT).

Coherent's stock is owned by many different of retail and institutional investors. Top institutional investors include Robecosam AG (0.54%), Envestnet Asset Management Inc. (0.04%), Pacer Advisors Inc. (0.04%), North Star Investment Management Corp. (0.03%), Supplemental Annuity Collective Trust of NJ (0.02%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Coherent stock include Bret Dimarco, Jay T Flatley, Mark Stewart Sobey, Pamela Fletcher, Paul F Sechrist, Sandeep Vij and Stephen A Skaggs. View Institutional Ownership Trends for Coherent.

COHR stock was sold by a variety of institutional investors in the last quarter, including Supplemental Annuity Collective Trust of NJ. View Insider Buying and Selling for Coherent.

COHR stock was bought by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., Robecosam AG, Oakbrook Investments LLC, State of Alaska Department of Revenue, Envestnet Asset Management Inc., North Star Investment Management Corp., Whittier Trust Co. of Nevada Inc. and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for Coherent.

Shares of COHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of COHR stock can currently be purchased for approximately $158.74.

Coherent has a market capitalization of $3.81 billion and generates $1.90 billion in revenue each year. The scientific and technical instruments company earns $247.35 million in net income (profit) each year or $13.04 on an earnings per share basis. Coherent employs 5,418 workers across the globe.View Additional Information About Coherent.

The official website for Coherent is http://www.coherent.com/.

Coherent's mailing address is 5100 Patrick Henry Drive, Santa Clara CA, 95054. The scientific and technical instruments company can be reached via phone at 408-764-4000.